ABSTRACT The gut barrier, comprising the microbiota and their products, mucus layers, host-derived antimicrobial compounds [e.g., host defense peptides (HDP), IgA], epithelium, and underlying immune tissues, performs the essential function of preventing the passage of harmful microorganisms and substances into the body, while enabling the acquisition of dietary nutrients. Antibiotic growth promoters (AGP) are widely accepted as the "gold standard" of performanceenhancing feed additives, which had become integral and valuable components of modern, efficient animal production, but are now being phased out in many parts of the world. This review, therefore, examines the reported effects of AGP on the key components of gut barrier function, particularly where corresponding (positive) growth performance data were provided to indicate that any changes were beneficial, and some important trends do emerge. Certain bacterial families (e.g., Lachnospiraceae), genera (e.g., Faecalibacterium, Propionibacterium, and Ruminococcus), or species (e.g., F. prausnitzii, B. fragilis, and some Lactobacillus spp.) have been reported to increase with AGP use, are associated with improved growth performance, and show benefit across species, which may be related to their production of short-chain fatty acids (SCFA). Various studies have investigated the effects of AGP on mucusrelated parameters (e.g., goblet cell size, density, and mucin mRNA expression) but these do not always seem to correlate well with the actual physical characteristics of the mucus layer(s). Surprisingly, there are little data relating to HDP or IgA, even though they have recognized benefits. There are clear AGP benefits on epithelial structure and function (e.g., nutrient digestibility), and these may (currently) provide the most reliable indicators of the efficacy of growth promoters. Data investigating effects on gut immune parameters (e.g., cell populations, cytokines, and chemokines), with corresponding growth performance, are limited and require further detailed interrogation. This review highlights both important observations related to the effects of AGP on key gut barrier components, with associated growth performance, and areas that require further investigation, thus providing an informative basis for assessing the potential of AGP alternatives.
INTRODUCTION
Antibiotic growth promoters (AGP) had become an integral, and valuable, component of efficient animal production, but their use is under pressure in many parts of the world (Gadde et al., 2017a) . AGP are invariably considered beneficial in commercial production and, by analyzing available data, Rosen (1995) concluded that they were effective 72% of the time, with typical growth and feed conversion efficiency improvements of 3 to 5% (Dahiya et al., 2006) . However, the published literature is probably C 2018 Poultry Science Association Inc. Received October 13, 2017. Accepted January 10, 2018. 1 Corresponding author: guthealthconsultancy@gmail.com biased by studies with positive outcomes, whereas some experiments may have been conducted in environments that were not commercially representative and thus too sanitary to elicit significant performance responses, or employed insufficient replication. Moreover, the frequent use of (the same) AGP in a given environment could potentially select for microbiota that are less responsive to their effects, and thus their efficacy may have diminished over time. Taken together, it is reasonable to suggest that AGP are effective, commercially, at least 50% of the time, but it is highly unlikely to be close to 100%, which should always be kept in mind. AGP are, however, often considered the "gold standard" of performance-enhancing feed additives and, in light of diminished usage, research is focused on finding suitable alternatives. Against this background, this review explores the key components of gut barrier function (please see Donaldson et al., 2016 , figure 2, for basic diagram of components), their potential modulation by growth promoter use, principally AGP where appropriate, and associations with improved animal performance. Understanding these potential relationships could provide critical insight into the desirable attributes of effective growth promoters.
MICROBIOTA AND THEIR PRODUCTS
The gut microbiota and their metabolites have a profound influence on the functioning of the intestine and thus the host. One of the clearest demonstrations of the protective effect of the microbiota and/or their components was performed by Nurmi and Rantala (1973) who reported that transferring "normal" adult gut microbiota to newly hatched chicks markedly increased their resistance to Salmonella infection, which led to the competitive exclusion concept. Similarly, germ-free animals have underdeveloped mucosal immunological tissues compared to conventional animals (Berg and Savage, 1975 ). These observations have been supported by experiments in various species that have employed administration of microbes and/or their components to prevent gastrointestinal (GI) disorders and/or to "normalize" immune capability (Caballero and Pamer, 2015) . For example, the intragastric administration of Faecalibacterium prausnitzii (or its culture supernatant) reduced the severity of colitis in a mouse model (Martin et al., 2014) , while Bacteroides fragilis, or, specifically, their polysaccharide A (PSA) surface component, enhance regulatory T cell (T reg) function (Mazmanian et al., 2005) . Strikingly, colonization with a single PSA-expressing B. fragilis strain can drive induction of colonic T reg (Round and Mazmanian, 2010) . Some of the benefits of the gut microbiota are thought to be due to their production of short-chain fatty acids (SCFA), primarily acetate, propionate, and butyrate, from complex carbohydrates (Rios-Covian et al., 2016) . Of these, butyrate, a direct source of energy for colonocytes, is probably the best known and is often considered the most important for intestinal health (van der Beek et al., 2017) , and could be responsible for the effects of F. prausnitzii (Rios-Covian et al., 2016) . Likewise, particular strains of Bifidobacterium longum were able to protect against enteropathogen infection, which was thought to be due to their production of acetate (Fukuda et al., 2011) . Interestingly, some of these bacteria, such as F. prausnitzii and B. fragilis, as well as the butyrate-producing Lachnospiraceae family, were associated with good performance in broiler chickens (Stanley et al., 2016) , and well-characterized strains could prove to be effective probiotic candidates.
Given the likely antimicrobial (even if below minimum inhibitory concentrations) effects of AGP (Broom, 2017) , it is interesting to consider the reported changes in microbial populations associated with improved AGP-related growth performance. Pourabedin et al. (2015) found that virginiamycin (16.5 g per ton of feed) improved feed conversion ratio (FCR) of (Ross) broiler chickens between 7 and 21 d of age, which was associated with greater abundance of Propionibacterium and Corynebacterium genera in the ileum (contents) but with no changes in relative abundances in the ceca, or overall microbial diversity at either site. In another study, zinc bacitracin (50 ppm) reduced FCR in (Cobb) broilers and increased the diversity of the cecal microbiota, with increases in Faecalibacterium and Ruminococcus torques phylotype, and reductions in Lactobacillus (primarily Lactobacillus salivarius phylotype) and Eubacterium (Crisol-Martínez et al., 2017) . In contrast, increased abundances of ileal Lactobacillus spp. (including L. aviarius and L. johnsonii) were associated with improved bodyweight (BW) of commercial turkey poults by 21 d when penicillin (50 g/ton) was added to a basal control diet containing bacitracin methylene disalicylate (BMD) (50 g/ton) (Danzeisen et al., 2015) . We should of course remember that due to differences in the spectrum of activities, differing gut microbiota effects could be expected between different AGP, and this has been demonstrated in a number of studies (e.g., Neumann and Suen, 2015; Costa et al., 2017) . However, studies that can relate AGP microbiota modulation with improved growth performance still provide valuable insight into potentially beneficial microbial shifts, and it is noteworthy that some lactobacilli have been correlated with poorer performance on several occasions (Torok et al., 2011; Stanley et al., 2014) .
Changes in the gut microbiota of pigs due to AGP supplementation, also using high-throughput sequencing (HTS) technologies targeting the 16S rRNA gene, have been reported too. For example, tylosin (40 g/ton) was shown to increase detection of fecal Lactobacillus (Kim et al., 2012a) , while a combination of chlortetracycline (100 g/ton), sulfamethazine (100 g/ton), and penicillin (50 g/ton) increased fecal Escherichia (Looft et al., 2012) and cecal and colonic Lachnobacterium, and reduced ileal, cecal, and colonic Streptococcus (Looft et al., 2014) . However, corresponding growth performance data were not provided to indicate whether these microbiota changes might be beneficial.
Unfortunately, across species, numerous studies investigating changes in microbial populations of farm animals fed AGP have either not reported the corresponding growth performance of the animals, which makes it impossible to infer whether any changes were beneficial, or have reportedly used potentially therapeutic antibiotic inclusions. In addition, where some studies do report animal performance and corresponding microbiota changes, it is not uncommon for only a single GI region (e.g., ceca or feces) or site (e.g., contents or mucosa) to be interrogated, thus eliminating the potential to reveal (any) influences of other locations. Older studies also are hampered by techniques available at the time, and thus the types of bacteria that could be cultured/identified, as well as the depth of interrogation possible.
Perhaps surprisingly, there is a relative dearth of data relating changes in SCFA with growth promoters, particularly AGP, and growth performance. However, virginiamycin (16.5 g/ton) did result in increased cecal propionate, which was positively correlated with the increased ileal abundance of the unique propionate producing genus, Propionibacterium (as outlined above), although this increase was detected many d after the period of improved performance (FCR) (Pourabedin et al., 2015) . More recently, the combination of neomycin and oxytetracycline increased cecal acetate, although this was not associated with improved growth or FCR (Kareem et al., 2017) . Both studies were conducted in broiler chickens.
MUCUS LAYER
Mucus layers, of varying thicknesses and compositions, provide the first host-derived line of defense in the intestine. The gel-like mucus traps invasive bacteria and promotes their expulsion from the intestine via luminal flow, as well as providing lubrication, and colonization sites and nutrients for commensal microbes . Goblet cells, a form of enterocyte, are responsible for the secretion of the large glycoprotein mucins that form the mucus layer(s) of the intestine. Mucins are classified as either membrane-bound or secreted, and MUC2 is the primary secreted mucin in the intestine of mammals (Chen et al., 2015) . Mucins can be further discriminated as either neutral or acidic (based on histochemical staining), and the latter are suggested to protect against bacterial translocation (Deplancke and Gaskins. 2001) . Goblet cells are located throughout the intestine, but their density increases distally as the density of microorganisms increases (Specian and Oliver, 1991) . There would appear to be an optimum mucus layer thickness, as its depletion is associated with some enteric infections (Wlodarska et al., 2011) and greater thickness with poorer performance, probably due to poorer diffusion of digestive enzymes and nutrients (Bontempo et al., 2006) and/or enhanced endogenous losses (Cowieson et al., 2016) . Various factors can influence the synthesis and secretion of mucin, such as diet, management (e.g., feeding practice), and also feed supplements that affect bacterial interactions with the intestinal epithelia (Lilburn and Loeffler, 2015) .
Our understanding of the precise role of goblet cells and mucin in "gut health," and particularly growth performance, is incomplete, but some studies have investigated these aspects in relation to feeding AGP. In broiler chickens (21 d), zinc bacitracin (50 ppm) increased goblet cell density (both acidic subtype and total) and size in the ileum, which corresponded to an improvement in both BW gain (BWG) and FCR (Chee et al., 2010) . However, BMD (50 ppm) did not result in altered MUC2 mRNA expression in (Ross) broilers at 14 d, even though BW and FCR were improved (Gadde et al., 2017b) . In weaned pigs (31 d), the combination of amoxicillin (25 ppm in feed and injection of 8·75 mg/kg BW every 12 h) and zinc oxide (ZnO) (2,500 ppm in feed) increased goblet cell density and average daily gain (ADG) (Thymann et al., 2007) . Interestingly, in a study in which growth performance was not reported, avilamycin (5 ppm) resulted in increased goblet cell density and mucin mRNA expression in both the jejunum and ileum of (Cobb) broiler chickens (14 d), but did not affect the thickness of the mucous adherent layer and, in fact, reduced mucin glycoprotein concentration in the duodenum (Smirnov et al., 2005) . Goblet cell size has been shown to increase in fasted chicks (similar cell density to non-fasted) but the mucus adherent layer thickness was decreased, which it was proposed was due to increased mucolysis (Smirnov et al., 2004) . Moreover, goblet cell size is likely a function of the interrelated dynamics of mucin production, storage, and secretion. Thus, the observations outlined above indicate that some typically measured mucus-related parameters (e.g., goblet cell size, density, mucin mRNA expression, etc.) may not correlate well with the actual physical characteristics of the mucus layer.
GLYCOCALYX
Together with the mucus layer, antimicrobial peptides (and secretory IgA) are integral components of the glycoprotein covering of the intestinal epithelium. Host defense peptides (HDP), also known as antimicrobial peptides (AMP), are expressed by a variety of cells but are commonly associated with Paneth cells and enterocytes. There are various classes of HDP: defensins, cathelicidins, S100 proteins, RNase A superfamily, regenerating islet-derived III (REGIII) C-type lectins, and peptidoglycan-recognition proteins. Currently, the genomes of pigs and chickens encode 29 and 14 β-defensin genes, respectively, but no α-defensins, while 4 and 11 cathelicidins are reported in chickens and pigs, respectively, with S100 proteins found in all vertebrates (Robinson et al., 2015) . HDP have been reported to have broad-spectrum (antimicrobial) activities against Gram-negative and Gram-positive bacteria, fungi, viruses, protozoa, as well as cancerous cells (Wang, 2014) . In addition, HDP are involved in the modulation of innate and adaptive immune responses and recent evidence highlights their direct role in regulating mucin and tight junction (TJ) protein expression and shaping microbiota composition (Robinson et al., 2015) . Studies have demonstrated that (even single) application of HDP protects animals in infection models (Bommineni et al., 2010) .
Immunoglobulin A is produced by plasma cells present in the lamina propria and can result from both T cell-dependent and independent pathways. Intestinal IgA is able to neutralize microorganisms and help facilitate their removal from the GI tract, as well as having further, more recently understood, roles in mucosal immunity and intestinal homeostasis, including establishment, maintenance, and control of commensal microbes (Mantis et al., 2011) . Polymeric IgA (the secreted IgA form) is transported across the intestinal epithelium into the gut lumen via polymeric immunoglobulin receptor (pIgR) expressed on the basolateral surface of epithelial cells . The secretory component (SC), the extracellular pIgR portion, is a key component of the secreted IgA (sIgA) complex and is thought to help protect sIgA against degradation from, e.g., intestinal proteases and also to help anchor sIgA in the mucus layer(s) (Kaetzel, 2005) . It has been reported that lamina propria IgA-positive cells and intestinal IgA levels are both significantly reduced in germ-free animals, which demonstrates the role of the gut microbiota, including specific bacterial species, such as segmented filamentous bacteria, in their modulation (Honda and Takeda, 2009 ).
There is a particular shortage of data investigating the effects of AGP on secretion of HDP or IgA in the intestine of farm animals under "normal" rearing conditions. However, a number of studies have reported improvements in growth performance of pigs (reviewed by Xiao et al., 2015) and poultry (Robinson et al., 2015) when feeding HDP from various sources, and under a variety of rearing conditions. Administration of HDP also has resulted in increased sIgA. Utilizing day-old, specific-pathogen-free chickens (Lohmann Brown), Wang et al. (2009) reported that intra musculi colli injection with AMP isolated from the intestines of pigs improved growth performance and resulted in increased expression of sIgA in the duodenum, jejunum, and ileum. Moreover, the benefits of probiotics and prebiotics on gut health have, at least in part, been associated with enhanced sIgA in the intestine (Bai et al., 2016; Deshpande et al., 2007) .
EPITHELIUM
The glycocalyx covers a single layer of epithelial cells that separate the host from the external environment. There are 4 major types of epithelial cells-goblet cells (mucin production), Paneth cells (HDP secretion), endocrine cells, and, principally, absorptive enterocyteswhich are organized as finger-like projections known as villi separated by recesses known as crypts. This arrangement increases the surface area available for digestion and absorption. As brush border digestive enzymes are attached to the epithelial surface, the intestinal surface area is directly proportional to digestive and absorptive, and thus feed conversion, efficiency (Collett, 2012) . Similarly, enterocytes functionally mature as they migrate from their source (crypt) to the villus tip, prior to being shed into the gut lumen, and the size of the crypts (e.g., deeper) reflects the rate at which epithelial cells are replaced (Collett, 2012) . To help form a continuous barrier and regulate paracellular permeability, the spaces between epithelial cells are sealed by TJ complexes. These TJ are multi-protein complexes that are composed of transmembrane proteins, primarily claudins and occludins, and regulatory molecules, such as kinases (Ulluwishewa et al., 2011) . As well as their critical role in digestive and barrier processes, intestinal epithelial cells (IEC) express pattern recognition receptors (PRR) (along with gut immune cells), thus contributing significantly to the host's (innate immune system's) ability to detect, monitor, and respond appropriately to intestinal microbes by recognizing their microbe-associated molecular patterns (MAMP) (Janeway and Medzhitov, 2002) .
There are various studies that have investigated the effects of AGP on gut epithelial-related function. Avilamycin (6 ppm) dietary supplementation of day-old (Ross) broilers improved BWG and FCR during a 42-day experiment, which was associated with reduced mucosal thickness and crypt depth in the ileum, and increased energy value of the diet, total tract crude fat, and ileal crude protein digestibility, including that of numerous amino acids (Kaczmarek et al., 2016) . Avilamycin (2.5 ppm) fed to day-old (Cobb) broilers improved nutrient digestibility and energy retention, while improving growth performance during a 42-day study period (Palamidi et al., 2017) . Further studies have found associations between enhanced intestinal morphology and/or nutrient digestibility and growth performance in broiler chickens (Choi et al., 2013; Kim et al., 2012b; Mountzouris et al., 2010; Sen et al., 2011; Vidanarachchi et al., 2010; Yang et al., 2008) and pigs (Zhou et al., 2012) fed AGPs. The reported improvements in fat digestion are consistent with suggestions that Lactobacillus spp. (including L. salivarius), having notable bile salt hydrolase activity, deconjugate bile salts, thus impairing fat digestion and absorption (Guban et al., 2006) , and that their suppression, including with AGP (Crisol-Martínez, 2017), may promote growth performance (Torok et al., 2011; Stanley et al., 2014) . In addition, alkaline phosphatase activity, which has been used as an indicator of intestinal maturation, has been reported to be greater in the ileum of superior performing, young (Ross) broiler chickens fed BMD (55 ppm) (Fasina and Thanissery, 2011) . Unfortunately, data relating to TJ changes associated with AGP feeding and enhanced performance are scarce. One study has reported no influence of BMD (50 ppm) on selected TJ protein mRNA expression of (Ross) broiler chickens at 14 d, but BW and FCR were improved (Gadde et al., 2017b) .
SUB-EPITHELIAL IMMUNE COMPONENTS
Beneath the epithelium is the lamina propria and gut-associated lymphoid tissue (GALT) with their associated immune cells. These tissues contain a variety of immune cells, including dendritic cells, macrophages, B/plasma cells, CD4+ (including regulatory) and CD8+ T cells, natural killer cells, and granulocytes (e.g., neutrophils/heterophils). Dendritic cells acquire antigen that breaches the epithelium, is present in phagocytosed epithelial cells, and/or by manipulating tight junctions and extending dendrites into the intestinal lumen to directly sample the contents (Stokes, 2017) . Following antigen acquisition, dendritic cells migrate to interact with, and activate, local naïve T cells. These interactions result in relevant immune cells secreting cytokines and chemokines that orchestrate an appropriate immune response. Thus, the gut immune system, along with epithelial cells, provides an effective surveillance and response system to intestinal microbes and antigens. As mentioned in previous sections, the important interactions between the gut microbiome and immune system are highlighted by germ-free animals having underdeveloped mucosal immunological tissues (Berg and Savage, 1975 ) and specific microbes, or their components, restoring aberrant immune function (Caballero and Pamer, 2015) .
Generally, few studies have reported effects of AGP on intestinal immune parameters where growth performance also was reported and improved. A combination of monensin (100 g/ton), BMD (50 g/ton), and roxarsone (45 g/ton) (0 to 35 d), followed by just virginiamycin (20 g/ton) (36 to 43 d), resulted in reduced CD4, CD8, and MHC2 and increased TCR2-expressing intraepithelial lymphocytes (IEL), with increased expression of IL-6, IL-17F, IFNγA, IL-13, TGFβ4, and CXCLi2, and reduced expression of IL-12 in 43-dayold broiler chickens raised on used litter (Lee et al., 2012) . In the same study, a similar antimicrobial combination, but with decoquinate (27 g/ton) replacing monensin during the first phase (0 to 35 d), reduced CD4, CD8, and MHC2, and increased BU1 and TCR2, expressing IEL, with enhanced expression of IL-4, IL-6, IL-13, and CXCLi2, and reduced expression of IL-2 and IL-12. This highlights the potential of these anticoccidial/AGP combinations to influence IEL subpopulations and their expression of a number of pro-inflammatory Th1 and Th2-related cytokines and chemokines. However, no growth performance data were provided to assess whether these changes were beneficial. A recent study did find that BMD (50 ppm) improved BW and FCR of (Ross) broiler chickens during their first 14 d of life, which was associated with increased ileal IL-6 and IL-13 expression (Gadde et al., 2017b) . IL-6 is often considered a pro-inflammatory cytokine that is produced by a variety of immune-related cells and is involved in the expansion and activation of T cells, the differentiation of B cells, and modulation of the acute-phase response. IL-13 is regarded as a key Th2 type cytokine, with effects on B cells and monocytes, IgE production, inflammatory cytokines, cellmediated immunity, and resistance to gastrointestinal infections (e.g., nematodes). Thus, potentially, BMD may influence both innate inflammatory and antibody responses to elicit positive performance improvements, but further studies would be required to delineate these effects.
CONCLUSIONS AND PERSPECTIVES
This review has attempted to collate available information relating changes in key components of gut barrier function, with improved growth performance, when feeding AGP to farm animals. Given their perceived status as the "gold standard" of performanceenhancing feed additives and use in various studies, including as positive controls, the relative shortage of available data, particularly corresponding growth performance, was somewhat surprising, and would limit the potential for meaningful meta-analysis. Thus, it is important that growth performance data, with sufficient replication, is routinely reported by future mechanistic studies. The review has avoided studies using specific challenge models. Although these experiments are very informative, observed changes are likely to be challenge specific and influenced by factors such as the organism, its virulence, dose, etc., which introduces further complication. Of course, health and sanitary conditions vary across studies, as well as the AGP and/or its inclusion, but important observations do emerge.
Our understanding of the gut microbiome and its desirable composition (and functional activity) is incomplete but is advancing, particularly since the application of recent HTS technologies, and provides some important insights across species. Enhanced abundance of particular bacterial families (e.g., Lachnospiraceae), genera (e.g., Faecalibacterium, Propionibacterium and Ruminococcus), or species (e.g., F. prausnitzii and B. fragilis) appear to be associated with improved gut health and growth performance, which may be related to their production of SCFA and/or their ability to modulate specific components of the intestinal immune system. Emerging evidence also challenges existing dogmas that certain bacteria can be considered simply as beneficial or not (e.g., lactobacilli) and highlights the importance of considering even strain level bacterial differences, probably due to their individual components/functional activities. Butyrate is widely accepted as beneficial to intestinal health, but it is impossible to draw any conclusions with regards to SCFA and performance from the available AGP data. AGP feeding has been associated with increases in both cecal propionate and acetate, but only the former could be associated with a period of improved growth performance. Data indicate an optimum mucus layer thickness, and perhaps composition, and that traditional indicators (e.g., goblet cell density, mucin mRNA expression, etc.) do not necessarily correlate well with the physical characteristics of the mucus layer. Thus, in future studies, it is likely to be more informative to assess the actual physical attributes of the mucus layer. The importance of sIgA, and more recently HDP and TJ complexes, are known but there is a paucity of information regarding their modulation in response to AGP use and growth performance, aspects which should be considered in future studies. There is greater clarity with epithelia structure and nutrient acquisition. AGP feeding generally results in improved intestinal structure, nutrient digestibility, and growth performance. Therefore, regardless of underlying mechanisms, these parameters remain important measures of gut function and the efficacy of growth promoters. Thus, interventions that seek to appropriately modulate the dynamics of IEC turnover (e.g., proliferation vs. loss), either directly or indirectly, could be worthy of investigation and development as AGP alternatives. In this regard, recent work in mice has indicated that Gram-positive intestinal bacteria and/or SCFA are major determinants of IEC turnover (Park et al., 2016) .
While the components of the gut barrier have been considered separately within this review, they do, of course, work in concert, with the potential to influence each other. As AGP alternatives, with equal efficacy and consistency, remain elusive, there is sufficient justification to more thoroughly investigate modulation of individual components of gut barrier function, as well as their interaction, and growth performance, utilizing the latest techniques, with AGP and most-promising alternatives. To enhance their scientific value, these studies should be broadly encompassing (e.g., parameters and samples), utilize appropriate, modern techniques, and be conducted in commercially representative environments. Such approaches should help to truly advance our understanding in this area and help deliver new, effective AGP alternatives for the animal production industry.
